MetaADEDB 2.0 @ LMMD
Fenretinide
(AKJHMTWEGVYYSE-FXILSDISSA-N)
Structure
SMILES
O=C(Nc1ccc(cc1)O)/C=C(/C=C/C=C(/C=C/C1=C(C)CCCC1(C)C)\C)\C
Type(s)
Investigational
Molecular Formula:
C26H33NO2
Molecular Weight:
391.546
Log P:
6.9353
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
49.33
CAS Number(s):
65646-68-6
Synonym(s)
1.
Fenretinide
2.
4-HPR
3.
4-Hydroxyphenylretinamide
4.
Fenretinide, 13-cis-Isomer
5.
Fenretinimide
6.
MCN-R-1967
7.
N-(4-Hydroxyphenyl)-trans-Retinamide
8.
N-(4-Hydroxyphenyl)retinamide
9.
13-cis-Isomer Fenretinide
10.
4 Hydroxyphenylretinamide
11.
Fenretinide, 13 cis Isomer
12.
MCN R 1967
13.
MCNR1967
External Link(s)
MeSHD017313
PubChem Compound5288209
BindingDB50092055
ChEBI42588
92493
CHEMBLCHEMBL7301
DrugBankDB05076
KEGGdr:D04162
Therapeutic Target DatabaseD08JAC
ZINC3871023
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Adenocarcinoma10697514CTD
2Anemia6226123CTD
3Brain Neoplasms16187019CTD
4Cerebral Hemorrhage2523991CTD
5Cervical Intraepithelial Neoplasia16154183CTD
6Colorectal Neoplasms17273769CTD
7Diabetes Mellitus, Experimental21591606CTD
8Fatty Liver21591606CTD
9Glioblastoma16187019CTD
10Hemangiosarcoma28973697CTD
11Insulin Resistance21591606CTD
12Leukoplakia, Oral16707609CTD
13Liver Neoplasms, Experimental17159502CTD
14Liver diseases6226123CTD
15Mammary Neoplasms, Experimental10697514CTD
16Mesothelioma21787763CTD
17Mouth Neoplasms16274795CTD
18Neoplasms15958647
17353921
20637870		CTD
19Neuronal Ceroid-Lipofuscinoses16303764CTD
20Obesity21591606CTD
21Prostatic Neoplasms17024972CTD
22Retinal Degeneration16303925CTD
23Skin Neoplasms16467112CTD
24Thrombocytopenia2523991CTD
25Vision Disorders2935125CTD
26leukemia2523991CTD
27melanoma16270382CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.